Location: Home
  • search
  • go
  • Board of Advisors
    Board of Advisors

    (in the order of last name)

    Dr. Eric Bouteiller International Advisor, Honorary Chairman of RDPAC and French Trade Advisor. Formerly General Manager of Ipsen China (2001–2011) and the company’s Senior Vice President for Asia Operations (2012-2017). Formerly Chairman for Tianjin Chapter of EUCCC (2008 to 2011) and formerly Vice Chairman (2011-2015) and Chairman (2016-2017) of RDPAC. (https://www.linkedin.com/in/eric-bouteiller-43136310/)

    Dr. Rob Bryant Principal, Brychem Business Consulting; and ex-Glaxo executive

    Peter Chua President, Association of Hong Kong Healthcare Professionals; Member, the Pharmacy & Poisons Board of the Hong Kong Government; President, Huatai Pharmaceutical, Hong Kong; Director, Beijing United Pharmaceutical; Justice of Peace (HK); and former President, Hong Kong Pharmaceutical Society.

    Dr. Vivian Chen Vice President, Corporate Affairs & Market Access, Ascletis Biotech; Formerly Senior Director, Abbott China; Vice President, Corporate Affairs & Government Relations, Eli Lilly China; and Director of Healthcare Economic Policy, RDPAC.

    Stanley Lau Co-Founder, iiTalent; and formerly COO, EddingPharm; President, China Biological Products Inc.; GM - Baxter China; GM – Schering Plough China; GM Asia – Searle/Pharmacia; and GM MSD - Taiwan

    Simon Luo Director of Operations and Country Manager, IQVIA Greater China; Board Director, Chinese Hospital Association; Senior Advisor, National Institute of Hospital Administration under the Ministry of Health; Advisor, China Association of Pharmaceutical Commerce; and Advisor, China Association of Chain Drug Stores.

    Robert Pollard Formerly Managing Director Asia Pacific, P/S/L Group Market Research; and Director Synovate Healthcare China.

    Dr. Xiaomei Li Reckford Formerly Vice President, China Strategic Growth, Quintiles Transnational Corporation; and CEO, Quintiles Greater China

    Dr. Yan Yan L Starkey Head of medical affairs, Great China and India, GE Healthcare, Life Science; and formerly Director, New Product Research China Liaison at GlaxoSmithKline Consumer Healthcare.

    Dr. Dong Xie Chairman and CEO, Frontier Biotechnology Ltd.

    Cheryl Q. Xu Public Policy & GA, Biogen; and formerly Advisor on China, Pharmaceutical Research and Manufacturers of America (PhRMA)

    Dr. Weiping Yang CEO, ApolloBio; and formerly President, Nanjing Tongrentang Pharma; Chairman and CEO, Fresenius Kabi China; and Director, RDPAC

  • Site map | Contact Us | Links
  • © Wicon International Group Support by: www.heightow.com